Full Press Release Details
Applied DNA Sciences Averages 35% Growth
Over Last Four Quarters
Announces Fourth Quarter and Fiscal Year
December 16, 2008/Market Wire/ -- Applied DNA Sciences, Inc. (OTC Bulletin
Board: APDN) announced today its revenues for the 4th quarter and fiscal year ending September 30,
"This year, APDN broadened its
commercial scope, gained traction for its multiple product offerings, expanded
its customer base and increased its revenues in each quarter of fiscal 2008,
averaging 35% growth quarter-over-quarter for the year. This builds on our
strategy of diversified revenue sources with managed risk concentration and
shortened sales cycles," stated Dr. James Hayward, President and
Key 2008 achievements
The Company has made significant inroads
with its central SigNature DNA platform that uses botanically derived genomic
DNA to mark and authenticate a range of security inks, packaging labels, and
event tickets. This year, APDN has been able to develop more market-ready
products, enabling faster price quotations and more concise product cycles which
will provide a foundation for continued growth in 2009.
"Despite the challenges of today's
economy, APDN continued to expand and grow in fiscal 2008. Our strategy remains
focused on long-term sustainable growth and although the economic realities may
impact us slightly in the short term, our long-term goals remain intact," stated
Kurt Jensen, Chief Financial Officer.
One of the key highlights of the year
for APDN was our launch into the world of textiles. In addition to marking
fabrics with our SigNature DNA, we authenticate natural fibers by genotyping,
analyzing the unique DNA content found naturally in these goods. Our newly
launched services for textiles include:
Dr. Benjamin Liang, Chief Technology
Officer, commented, "Our FiberTyping test, which was developed to help the
cotton industry, is ready for commercial use. We believe that the experience we
bring to cotton will also be of great value to the wool industry. We are looking
forward to our business collaborations with Supima and the Yorkshire companies in marking and authenticating
textile and apparel in the new year."
"We are grateful for the strong support
of our customers, strategic partners, employees and investors this year. We have
made significant progress toward our goals and we believe our vision and
strategy will take us there," continued Dr. Hayward.
Applied DNA Sciences markets and sells
DNA encrypted and embedded solutions that are forensically authenticated by
machine readable devices. These solutions can be easily integrated with a range
of inks, threads, varnishes, adhesives as well as thermal ribbon, inkjet and
laser ink. Applied DNA Sciences' products can help protect the brands and
intellectual property that can easily be eroded by counterfeiting, product
diversion and fraud.
The statements made by APDN may be
forward-looking in nature and are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements
describe APDN's future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and uncertainties, many of
which are beyond the control of APDN. Actual results could differ materially
from those projected due to our short operating history, limited financial
resources, limited market acceptance, market competition and various other
factors detailed from time to time in APDN's SEC reports and filings, including
our Annual Report on Form 10-K, filed on January 15, 2008 and our subsequent
quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly
any forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of unanticipated
SOURCE Applied DNA Sciences,
INVESTOR CONTACT: Debbie Bailey,
631-444-8090, fax: 631-444-8848/
MEDIA CONTACT: Deanne Eagle,
212-554-5436 /FCMN Contact: info@adnas.com / /
Web site: http://www.ADNAS.com